- Choroideremia
- Hereditary choroidal dystrophy
- Inherited retinal degeneration
- Pigmentary retinopathy
- Retina degeneration
- Retinal angiomatosis in von Hippel-Lindau disease
- Retinitis pigmentosa
- Stargardt's disease vision
- Usher's syndrome-related retinal disorders
Tomas S. Aleman, MD
Ophthalmology
Accepting new patients
Sees patients age 4 and up
Scheie Eye Institute Perelman
Penn Medicine Provider
About me
- Director, Retinal Function and Structure Laboratories, Scheie Eye Institute
- Director, Retinal Degenerations, Scheie Eye Institute
- Director, Retinal Degeneration and Ophthalmic Genetics Fellowship Program, Scheie Eye Institute
- Irene Heinz-Given and John LaPorte Research Professor
My education and training
- Medical School: Universidad de Ciencias Medicas de la Habana
- Residency: INTEGRIS Rural Healthcare of Oklahoma
- Residency: Brookdale Hospital Medical Center
- Residency: Scheie Eye Institute
- Fellowship: Scheie Eye Institute
Spoken languages
English
English
Español
Spanish
Reviews
561 reviews
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Insurance accepted
Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
- Devoted Health Choice Giveback Pennsylvania (PPO)
- Devoted Health Choice Pennsylvania (PPO)
- Devoted Health Choice Plus Pennsylvania (PPO)
- Devoted Health Core Pennsylvania (HMO)
- Devoted Health Dual Plus Pennsylvania (HMO D-SNP)
- Devoted Health Giveback Pennsylvania (HMO)
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
- Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Qualifications and experience
- Ophthalmology, 2019
- American Academy of Ophthalmology, National
- Association for Research in Vision and Ophthalmology, International
- Cuban Society of Ophthalmology, National
- Cuban Society of Retinitis Pigmentosa, National
- The International Society for Genetic Eye Disease and Retinoblastoma, International
- The Macula Society, International
Treatments and conditions
Research
Publications
Dufour VL, Sato Y, Sumaroka A, Sudharsan R, Banin E, Yu Y, Ripolles-Garcia A, Kwok J, Aleman TS, Ying GS, Sharon D, Cideciyan AV, Beltran WA, Aguirre GD PRCD-associated retinitis pigmentosa in dogs and humans , Exp Eye Res, 269: 2026,111045
Hüther A, Simon CL, Sumaroka A, O’Neil EC, Roman AJ, Kim RJ, Weber, Garafalo AV, Cideciyan AV, Aleman TS Bi-allelic pathogenic variants in NR2E3 may be associated with a subtle enhanced S-cone syndrome phenotype , Ophthalmic Genetics, 30: 2026,1-7
Cideciyan AV, Aleman TS Gene therapy for young children with congenital blindness , The Lancet, 144(2): 2026,165-166
Aleman TS, Cideciyan AV Measuring vision in children undergoing retinal gene therapy , JAMA Ophthalmol, 144(2): 2026,165-166
Zhang S, Avery RA, Wu V, Sumaroka A, Kim RJ, Maripuri DP, Datz E, Weber ML, Roman SJ, Tsang SH, Cideciyan AV, Aleman TS, O’Neil EC A Spectrum of severity of a unifying retinal phenotype in TUBB4B-associated inherited retinal degeneration , Retina Cases and Brief Reports: 2026
Darrah S, Xu P, Wendel BJ, Liu T, Warner RL, Jiang Y, Bharadwaj P, Kreis J, Wong J, Aleman TS, Cideciyan AV, Mustafi D, Chao JR, Carroll J, Duncan JL, Morgan JIW, Sabesan R. Baseline optoretinography for retinitis pigmentosa patients enrolled in the NAC Attack phase-III clinical trial AOSLO ancillary study , Invest. Ophthalmol. Vis. Sci.: 2026
O’Neil EC, Roman AJ, Wu V, Garafalo AV, Weber ML, Aleman TS, Cideciyan AV. Behavioral assessment of rod and cone sensitivity in young patients with inherited retinal disease: Development of Pediatric Dark-adapted Stimulus Test (PDST) , Invest. Ophthalmol. Vis. Sci.: 2026
Weber M, Cideciyan AV, O'Neil EC, Roman AJ, Sumaroka A, Swider M, Maguire K, Aleman EM, Kim RJ, Santos A, Parchinski K, Viarbitskaya I, Wu V, Garafalo AV, Michaelides M, Tsang SH, Pfau M, Moosajee M, Levin AV, Pierce EA, Comander J, Maguire AM, Scoles D, Bennett J, Aleman TS. Natural history of Leber Congenital Amaurosis associated with pathogenic variants in Lebercillin (LCA5): Cross-sectional and longitudinal observations , Invest. Ophthalmol. Vis. Sci.: 2026
Wu V, Roman AJ, Aleman TS, Cideciyan AV. Measuring rod- and cone-photoreceptor specific sensitivity with the Full-field Stimulus Test (FST) in inherited retinal diseases , Invest. Ophthalmol. Vis. Sci. : 2026
Sumaroka A, Bowles-Johnson K, Wu V, Garafalo AV, Viarbitskaya I, Aleman TS, Beltran WA, Miller DT, Cideciyan AV. Early features of ABCA4-associated Stargardt disease (ABCA4-STGD) in the extrafoveal perilesional retina , Invest. Ophthalmol. Vis. Sci.: 2026